Publicationsadmin2016-12-06T22:53:49-06:00 PublicationsShow AllOur ProductsStem CellAlternative CancerIntravenous Vitamin CDendritic Cell TherapyOther Safety of targeting tumor endothelial cell antigensApril 2016Modulation of Cytokines in Cancer Patients by Intravenous Ascorbate TherapyJanuary 2016Case report of non-healing surgical wound treated with dehydrated human amniotic membraneJuly 2015Scalable efficient expansion of mesenchymal stem cells in xeno free media using commercially available reagentsJuly 2015Metabolic correction: a functional biochemical mechanism against disease--Part 1: concept and historical backgroundMarch 2015A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methodsOctober 2014Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapyMay 2014Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patientsAugust 2013The bio-energetic theory of carcinogenesis.October 2012Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safetyFebruary 2012Schedule Dependence in Cancer Therapy: Intravenous Vitamin C and the Systemic Saturation HypothesisJanuary 2012The king is dead, long live the king: entering a new era of stem cell research and clinical developmentDecember 2011IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?October 2011Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?June 2011Increased Level of Circulating Endothelial Microparticles and Cardiovascular Risk FactorsApril 2011Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?March 2011On the missing link between inflammation and cancerJanuary 2011Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasiaJanuary 2011Outstanding Survival and Regeneration Process by the Use of Intelligent Acellular Dermal Matrices and Mesenchymal Stem Cells in a Burn Pig ModelDecember 2010Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4December 2010Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case reportNovember 2010Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factorsJune 2010Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?June 2010Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditionsAugust 2010Immunotherapy for melanoma: current status and perspectivesJuly 2010Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic diseaseApril 2010Tumor vaccines in 2010: need for integrationApril 2010Combination stem cell therapy for heart failureApril 2010Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjectsApril 2010The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitroFebruary 2010The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cellsJanuary 2010Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivoJanuary 2010Circulating endothelial progenitor cells: a new approach to anti-aging medicine? December 2009Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophyOctober 2009Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosisApril 2009Feasibility investigation of allogeneic endometrial regenerative cellsFebruary 2009Inhibition of intracranial glioma growth by endometrial regenerative cellsFebruary 2009Anti-angiogenic effect of high doses of ascorbic acidSeptember 2008Allogeneic endometrial regenerative cells: an ``Off the shelf solution`` for critical limb ischemia? August 2008Granulocyte activity in patients with cancer and healthy subjectsSeptember 2008Exosomes as a tumor immune escape mechanism: possible therapeutic implicationsAugust 2008Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth diseaseMay 2008Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathyJune 2008Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbateMarch 2008Antigen-specific therapy of rheumatoid arthritisFebruary 2008Endometrial regenerative cells: a novel stem cell populationNovember 2007Stem cell therapy for autismJune 2007Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancerApril 2009Cord blood in regenerative medicine: do we need immune suppression?January 2007Therapeutic use of Aldara in chronic myeloid leukemiaJanuary 2007Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kineticsMarch 2006Induction of antitumor immunity through xenoplacental immunizationMay 2006A pilot clinical study of continuous intravenous ascorbate in terminal cancer patientsDecember 2005A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixturesJanuary 2006Cancer is a functional repair tissue2006Orthomolecular oncology review: ascorbic acid and cancer 25 years laterMarch 2005Intravenous vitamin C as a chemotherapy agent: a report on clinical casesJune 2004Cell membrane fatty acid composition differs between normal and malignant cell linesJune 2004L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60October 2004Intravenous ascorbic acid: protocol for its application and useSeptember 2003Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLITE-FLITE randomized, controlled trialSeptember 2003Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesisDecember 2002Inhibition of human breast carcinoma cell proliferation by ascorbate and copperMarch 2002Integrative medicine: a paradigm shift in medical education and practiceDecember 2000Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumoursJune 2001Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agentMarch 1995Improved microplate fluorometer counting of viable tumor and normal cellsMay 1994
